THE ROLE OF NOTCH IN TUMORIGENESIS: ONCOGENE OR TUMOUR SUPPRESSOR? Notch Speakers: 葉恭誌 李昭鋐 組員 : 林雅葶 張明俐 羅苑菁 鄭伯忻 曾昭穎 蔡志文 陳美君 江承堯 高家民 呂女秀菱.

Slides:



Advertisements
Similar presentations
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
Advertisements

Notch receptor activation and function. Lz Notch signaling completely changes the way that cells respond to other signaling pathways Flores et al., Cell.
Next lecture: Induction/Signaling Requirements of inducer and responder cells Cascades of inductive events are involved in forming organs Examples of the.
CELLULAR SIGNAL TRANSDUCTION 2) From the membrane to the nucleus TEIL F TRANSCRIPTION FACTORS AND THE REGULATION OF TRANSCRIPTION Rainer deMartin / Erhard.
Notch and T-cell acute Lymphoblastic leukemias by Ana Ruth Cerna March 2 th, 2006.
Stem Cells and Cell Signaling
Neurotrophin Signaling (Trk Signaling Pathway). Neurotrophins The neurotrophins are a family of proteins that are essential for the development of the.
Lecture 11: Signalling for Life/Death 1)Describe the eukaryotic cell cycle and the purpose of checkpoints. 2)Describe the role of cyclins and cyclin-dependent.
ApoptosisNecrosis Apoptosis is a form of programmed cell death Apoptosis is responsible for the formation of digits in the developing mouse paw. Apoptotic.
HOXA9 – AcuteMyeloidLeukemia. HOX Genes encode transcription factors
E2A and acute lymphoblastic leukemias (ALL). A closer look at the E2A gene... Other names: TCF3, ITF1, and Factors E12/E47 Located on chromosome 19 Encodes.
Notch1 Transmembrane Receptor Oncogene. What is Notch1?  Transmembrane protein involved in a conserved and simple signaling pathway.
Notch1 and pre-T-cell Acute Lymphoblastic Leukemia (T-ALL) by Lindsey Wilfley.
T-cell receptor Complex: TCR + CD3  and  result from differential RNA splicing Immunoreceptor tyrosine-based activation motif.
Notch1 and its role in pre T-cell Acute Lymphoblastic Leukemia (ALL) By Rebecca Goodman.
BioSci 145A lecture 18 page 1 © copyright Bruce Blumberg All rights reserved BioSci 145A Lecture 18 - Oncogenes and Cancer Topics we will cover today.
Copyright (c) by W. H. Freeman and Company Chapter 24 Cancer.
Retinoic Acid Receptor Alpha and Acute Promyelocytic Leukemia Nidhi Thapar April 1, 2004.
E2A – bHLH transcription factor-fusion proteins in Leukemia
NOTCH-1 PRE-T-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS.
Chapter 20 oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU.
RET Proto-Oncogene of Multiple Endocrine Neoplasia type 2(MEN2)
Chapter 10 T-Cell Maturation, Activation, and Differentiation.
Cell Signaling Lecture 13 and 14. Ligand-activated Notch undergoes 2 cleavages before releasing the transcription factor ADAM10: A disintegrin and Metalloprote.
Malignant Melanoma and CDKN2A
Viruses and Cancer BTY328: Virology
Tumor genetics Minna Thullberg
Chromosomally unstable mouse tumors have genomic alterations similar to diverse human cancers Journal Club
NOTES: CH 18 part 2 - The Molecular Biology of Cancer
Cellular Senescence: A Link between Tumor Suppression and Organismal Aging.
Cell-cell Communications in Development
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
1. p53 Structure, Function and Therapeutic Applications Provider: Dr.Davood Nourabadi(PhD,medical physiology) mdphysiology.persianblog.ir.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
P57, Tumorigenesis, and Beckwith-Wiedemann Syndrome Ashley Albright.
Gene Expression. Cell Differentiation Cell types are different because genes are expressed differently in them. Causes:  Changes in chromatin structure.
BRG-1 in Cancer BRG-1 is an ATPase subunit of the SWI/SNF class of chromatin remodeling complexes It has been found mutated in a number of cancer cell.
Apoptosis in Cancer By: Karen Hutcherson Ryan Jenkins Angie Lam Jennie Zaborsky ISAT
The Generation and Survival of Nerve Cells
Benign Versus Malignant Tumors
E2A and Acute Lymphoblastic Leukemia (ALL) Jeremy Petree.
Telomerase, Immortalization and Cancer Eric Bankaitis Cancer Bio 169 March 9, 2006 Fig.[9]
“Because clinical experience is still so limited, it is not possible to exclude longterm adverse effects of gene transfer therapy, such as might arise.
Section S Tumor viruses and oncogenes
Repair Dr Heyam Awad FRCPath. Tissue repair Restoration of tissue architecture and function after injury. Two types : 1) regeneration. 2) scar formation.
T-Cell Maturation, Activation, and Differentiation
1 time * transcription factors expressed in large blocks
Lecture 12: Cancer: a cellular perspective Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics and Molecular.
Oncogenes Lecture 43BSCI 420,421,620Dec 13, 2002 “It ain’t over till the fat lady sings” – Joe Gibbs 1.Cancer-critical genes a. Oncogenes b. Tumor-suppressor.
Bmi-1 in Cancer Cancer genetics 2012/04/ 전종철
Retinoic Acid Receptor α Acute Promyelocytic Leukemia Michi Nair.
Viral transformation and oncogenesis Fahareen –Binta –Mosharraf MNS.
IMMUNOLOGICAL TOLERANCE. BASIC FACTS ABOUT TOLERANCE Tolerance – a state of unresponsiveness specific for a given antigen It is specific (negative) immune.
The Organization and Control of Eukaryotic Genomes Ch. 19 AP Biology Ms. Haut.
Development, Stem Cells, and Cancer
The Role of Notch1 signaling in T-cell acute lymphoblastic leukemia
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
Notch1 and its role in pre-T-cell acute lymphoblastic leukemia (T-ALL)
Regulator of the apoptotic pathway
(T-cell Acute Lymphoblastic Leukemia)
Yee-Ming Chan, Yuh Nung Jan  Neuron 
An Invitation to T and More
Notch: Architect, Landscaper, and Guardian of the Intestine
Panagiotis Ntziachristos, Jing Shan Lim, Julien Sage, Iannis Aifantis 
Yee-Ming Chan, Yuh Nung Jan  Neuron 
Notch and the Immune System
Notch signaling from tumor cells: A new mechanism of angiogenesis
Tenets of PTEN Tumor Suppression
N1 decoys differently inhibit ligand-induced NOTCH signaling.
Notch and the Immune System
Presentation transcript:

THE ROLE OF NOTCH IN TUMORIGENESIS: ONCOGENE OR TUMOUR SUPPRESSOR? Notch Speakers: 葉恭誌 李昭鋐 組員 : 林雅葶 張明俐 羅苑菁 鄭伯忻 曾昭穎 蔡志文 陳美君 江承堯 高家民 呂女秀菱

- In 1917,Thomas Hunt Morgan and colleagues described a strain of Drosophila with notches at the end of their wing blades. Notch: - Genetics: Haploinsufficiency - Structure: transmembrane receptor notch

Structure : transmembrane receptor Lin12 repeats (cysteine-rich) CDC10 repeats Nuclear-localization signal Transcription activation domain Synthesized as a single precursor protein Cleaved in two during its transport to the cell surface. Drosophila Notch receptor Ligand (Delta) (Serrate)

Notch receptor LigandHuman Slight difference EGF LNRAMANK TADPEST (Ser-like)

Notch signaling (Notch IC) Notch absence: transcription repressor Notch present: Transcription activator Translocate into nucleus and bind to transcription factor CSL Activation leads to cleavage IC domain -HES (hairy/enhancer of split) family of transcription factors -cell-cycle regulator-Waf1  Different modification of Notch and signal crosstalk influence Notch activation.  Different cell type uses different signal.

Notch function

Maintenance of an undifferentiated state –Notch signaling can maintain stem cells or precursor populations in an undifferentiated state. –Gain-of-function studies : (in the chicken) using a dominant active Notch-IC : Notch signaling prevents progenitors from undergoing neurogenesis. blocking the Notch pathway : excessive neurogenesis and depletion of the progenitor pool. Notch function Lewis, J. (1998) Semin. Cell Dev. Biol. 9, 583–589 Henrique, D. (1997) Curr. Biol. 7, 661–670

Participate in Cell-fate decision Epidermal cell Neuronal cell Equitpotent cell ? Differentiation receptor ligand During the development of neuronal-precursor cells of the sensory organ in Drosophila.

Inductive cell-fate determination Notch signal Cell differentiation Example : bipotential mouse neural-crest stem cell adopt to glial cell. Early lymphocyte precursors T-cell B-cell Mouse thymic epithelial cell

–DLL1-induced Notch signaling initiates a terminal-differentiation program in human skin. –Other possible mechanism (Jagged- mediated) : activated Notch1 causes keratinocyte growth arrest through increased p21 WAF1/Cip1 expression. —Rangarajan, A. (2001) EMBO J. 20, 3427–3436 Induction of terminal differentiation

Notch as an oncogene

Notch and T-cell leukaemia Translocation of a portion of chromosome 7 to chromosome 9, which contains T-cell receptor-  gene. Expreesion of truncated NOTCH1 transcripts (similar to NOTCH1-IC) from TCR  promoter causes T-cell acute lymphoblastic leukaemia (T-ALL). Ellisen, L. W. et al. Cell 66, (1991).

Hot spots of mutations found in more than 50% of T-ALL patients HD: heterodimerization domain P: pest domain. Weng AP. et al.Science 306:269–271(2004)

Why does the hematopoietic oncogenic potential seem to be restricted to T cell leukemia? Mice transplanted with Notch1-IC-expressing bone-marrow-progenitor cells from either Rag2–/– or Slp76 –/– mice failed to develop T-cell leukaemia. Introduction of a TCR βtransgene into Rag2–/– mice — to re-activate pre- TCR signalling — restored the oncogenic function of Notch1-IC. Allman, D. et al. J. Exp. Med. 194, 99–106 (2001). Notch1-IC-mediated transformation is dependent on a second T- cell-specific signal that is mediated by the pre-TCR.

Notch and viruses Proviral integration of the Moloney murine-leukaemia virus (MuLV) into the murine Notch1 locus causes T-ALL in mice. Integration of the mouse mammary tumour virus (MMTV) in between the Notch/Lin12 repeats and the transmembrane domain of either the Notch1 (NI) or Notch4 (N4) gene causes mammary tumours in the mouse.

Notch and Epithelial tumours Transgenic mice that express this Notch4-IC/int-3 gene developed poorly differentiated mammary and salivary-gland adenocarcinomas within 7 months. The mammary epithelial of these mice failed to branch.

Notch-IC (1) RAM domain : CBF binding site (2) ankyrin repeat domain (ANK) : mediates further protein- protein interactions (3) C-terminal domain : a polyglutamine region (OPA) + proline, glutamic acid, serine and threonine rich region (PEST) (4) NLS : nuclear localization sequence

How can Notch contribute to transformation? CBF1 is a sequence specific DNA binding protein that functions to repress transcription of cellular genes In some cells, Notch-assisted transformation is dependent on the ankyrin repeats of the Notch protein, not CBF1

MOLECULAR AND CELLULAR BIOLOGY, June 2000, p. 3928–3941 E1A-immortalized baby rat kidney cell line (RKE)

Notch needs to partner another oncoprotein to actually cause cancer Virology 286, 23±30 (2001) Transformation can be induced by expressiong Notch-IC with oncoproteins such as adenovirus EIA,HPV E6 and E7… AcN1: a truncated allele of Notch1

These oncoproteins all share the common property of being able to override the G1-S checkpoint resistance to apoptosis, anoikis or differentiation ANOIKIS: Cell death induced as a result of the absence of matrix attachment

The oncogenic effects of Notch include PI3-K activation and induction of ERBB2 and NF- ĸB2 expression (by NOTCH-IC) PI3-K resistance to anoikis ERBB2 cell proliferation and growth NF-ĸB2 expression of genes which encode anti-apoptotic proteins

Notch1 as tumour suppressor NOTCH1 signaling increases expression of WAF1, which causes cell-cycle arrest in basal cells, to allow the onset of terminal differentiation

In Notch1-ablated skin, reactivation of Wnt and Sonic- hedgehog pathways result in the development of basal-cell- carcinoma-like tumours in the mouse. The tumour-suppressive activity of NOTCH1 might be mediated by several routes, to induce cell-cycle arrest and differentiation Tumour cells might counter-select against expression of Notch receptors or ligands to escape from differentiation and cell-cycle arrest

The two faces of Notch in cervical cancer

Proteins are increasingly being found to have several and possibly opposing functions

HPV was found in 99% cervical cancers

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p Cell Telomerase activation by the E6 gene product of human papillomavirus type Nature => E6 and E7 are oncoproteins in cervical cancer cells

=>Notch prevent cellular proliferation in normal epithelia =>upregulate WAF1 =>cells initiation of differentiation BUT…..

Conclusion The outcome of Notch activation is dependent on cellular context

Thank you